Scorpius Holdings, Inc. (SCPX)
- Previous Close
0.1320 - Open
0.0410 - Bid 0.0457 x 4000
- Ask 0.0500 x 1100
- Day's Range
0.0579 - 0.1311 - 52 Week Range
0.0300 - 800.0000 - Volume
1,313,189 - Avg. Volume
840,736 - Market Cap (intraday)
264,655 - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
-- - EPS (TTM)
-1,901.4900 - Earnings Date Apr 30, 2025 - May 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
www.scorpiusbiologics.comRecent News: SCPX
View More
Performance Overview: SCPX
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SCPX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SCPX
View MoreValuation Measures
Market Cap
237.44k
Enterprise Value
10.32M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.00
Price/Book (mrq)
0.01
Enterprise Value/Revenue
1.03
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-286.88%
Return on Assets (ttm)
-33.61%
Return on Equity (ttm)
-106.89%
Revenue (ttm)
10.04M
Net Income Avi to Common (ttm)
-29.66M
Diluted EPS (ttm)
-1,901.4900
Balance Sheet and Cash Flow
Total Cash (mrq)
4.81M
Total Debt/Equity (mrq)
60.69%
Levered Free Cash Flow (ttm)
-11.41M